Safety and growth suppressive effect of intra-hepatic arterial injection of AdCMV-p53 combined with CDDP to rat liver metastatic tumors

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 3, 2003, Pages 399-406

  Okimoto, Tatsuya ^a,c   Yahata, H ^a   Itou, H ^b   Shinozaki, K ^a   Tanji, H ^a   Sakaguchi, T ^a   Asahara, T ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CDDP; Hepatic artery; Metastatic liver tumor; p53

Indexed keywords

ADENOVIRUS VECTOR; CISPLATIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG SAFETY; GENE DELIVERY SYSTEM; GENE THERAPY; HEPATIC ARTERY; INTERMETHOD COMPARISON; LIVER METASTASIS; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; CYTOMEGALOVIRUS; DISEASE PROGRESSION; GENE THERAPY; INJECTIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; NEOPLASM METASTASIS; RATS; RATS, INBRED F344; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0141447440     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lau H., Fan S., Ng I.O., Wong J.: Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer 83:2302-2311, 1998.
2. Oda T., Tsuda H., Scarpa A., Sakamoto M., Hirohashi S.: p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 52:6358-6364, 1992.
3. Nishida N., Fukuda Y., Kokuryu, H., et al.: Role and mutation heterogeneity of the p53 gene in hepatocellular carcinoma. Cancer Res. 53:368-372, 1993.
4. Braithwaite A.W., Sturzbecher H.W., Addison C., Palmer C., Rudge K., Jenkins J.R.: Mouse p53 inhibits SV40 origin-dependent DNA replication. Nature 329: 458-460, 1987.
5. Fujimoto Y., Kohgo Y.: Alteration of genomic structure and/or expression of cancer associated genes in hepatocellular carcinoma. Rinsho-Byori. 46: 9-14, 1998.
6. Zhang W.W., Alemany R., Wang J., Koch P.E., Ordonez N.G., Roth J.A.: Safety evaluation of Ad5CMV-p53 in vitro and in vivo. Hum Gene Ther. 6:155-164, 1995.
7. Bouvet M., Ellis L.M., Nishizaki M., et al.: Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer. Cancer Res. 58: 2288-2292, 1998.
8. Inoue Y., Kashima Y., Aizawa K., Hatakeyama K.: A new rat colon cancer cell line metastasizes spontaneously: biologic characteristics and chemotherapeutic response. Jpn. J. Cancer Res. 1: 90-97, 1991.
9. Huard J., Lochmuller H., Acsadi G., Jani A., Massie B., Karpati G.: The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2: 107-115, 1995.
10. Arbuthnot P.B., Bralet M.P., Le Jossic C., et al.: In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther. 7: 1503-1514, 1996.
11. Lan K.H., Kanai F., Shiratori Y., et al.: Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors. Gastroenterology 111: 1241-1251, 1996.
12. Bui L.A., Butterfield L.H., Kim J.Y., et al.: In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. Hum Gene Ther. 8: 2173-2182, 1997.
13. Stagg R.J., Lewis B.J., Friedman M.A., Ignoffo R.J., Hohn D.C.: Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann. Intern. Med. 100: 736-743, 1984.
14. Anderson S.C., Johnson D.E., Harris M.P.: p53 Gene Therapy in a Rat Model of Hepatocellular Carcinoma: Intra-Arterial Delivery of a Recombinant Adenovirus. Clin Cancer Res. 4: 1649-1659, 1998.
15. Gerolami R., Cardoso J., Bralet M.P., et al.: Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery. Gene Ther. 5: 896-904, 1998.
16. Kwon H.C., Kim J.H., Kim K.C., et al.: In vivo antitumor effect of herpes simplex virus thymidine kinase gene therapy in rat hepatocellular carcinoma: feasibility of adenovirus-mediated intra-arterial gene delivery. Mol. Thr. 11: 170-178, 2001.
17. Maron D.J., Tada H., Moscioni A.D., et al.: Intra-arterial delivery of a recombinant adenovirus does not increase gene transfer to tumor cells in a rat model of metastatic colorectal carcinoma. Mol. Thr. 4: 29-35, 2001.
18. Kuruppu D., Christophi C., Bertman J.F., O'brien P.E.: Liver and Billiary Characterization of an animal model of hepatic metastasis. J. Gastroenterol. Hepatol. 11: 26-32, 1996.
19. Raper S.E., Haskal Z.J., Ye X., et al.: Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses. Hum. Gene Ther. 9: 671-679, 1998.
20. Nunes F.A., Furth E.E., Wilson J.M., Raper S.E.: Gene Transfer into the Liver of Nonhuman Primates with E1-Deleted Recombinant Adenoviral Vectors: Safety of Readministration. Hum. Gene Ther. 10: 2515-2526, 1999.
21. Schnell M.A., Zang Y., Tazelaar J., et al.: Activation of Innate Immunity in Nonhuman Primates Following Intraportal Administration of Adenoviral Vectors. Mol. Thr. 3: 708-722, 2001.